LAB — Standard Biotools Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Standard Biotools, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28.5	166	115	293	188
Net Total Accounts Receivable
Net Total Receivables	18.3	17.3	19.7	33.6	13.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	72.1	209	158	376	454
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	65.2	59.5	54.9	71.4	46
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	275	390	323	612	568
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	49.6	43.4	109	65.9	108
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	181	161	160	141	143
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	94.6	230	163	472	424
Total Liabilities & Shareholders' Equity	275	390	323	612	568
Total Common Shares Outstanding